Skip to main content

Artificial Intelligence

0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
DeFrameN/A1 trial
Active Trials
NCT05687318Completed337Est. Aug 2023
Cosmo Pharmaceuticals
Cosmo PharmaceuticalsIreland - Dublin
1 program
GI Genius CADe systemN/A1 trial
Active Trials
NCT04589078Completed200Est. Dec 2020
Partner Therapeutics
Partner TherapeuticsMA - Lexington
1 program
Retinal diseases diagnosed by artificial intelligence algorithmN/A1 trial
Active Trials
NCT04678375Completed1,000,000Est. Oct 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
UNION therapeuticsDeFrame
Cosmo PharmaceuticalsGI Genius CADe system
Partner TherapeuticsRetinal diseases diagnosed by artificial intelligence algorithm

Clinical Trials (3)

Total enrollment: 1,000,537 patients across 3 trials

NCT05687318UNION therapeuticsDeFrame

A Clinical Trial of the Effectiveness and Safety of Software Assisting Diagnose the Intestinal Polyp Digestive Endoscopy by Analysis of Colonoscopy Medical Images From Electronic Digestive Endoscopy Equipment

Start: Sep 2022Est. completion: Aug 2023337 patients
N/ACompleted
NCT04589078Cosmo PharmaceuticalsGI Genius CADe system

Polyp REcognition Assisted by a Device Interactive Characterization Tool - The PREDICT Study

Start: Sep 2020Est. completion: Dec 2020200 patients
N/ACompleted
NCT04678375Partner TherapeuticsRetinal diseases diagnosed by artificial intelligence algorithm

Artificial Intelligence for Detecting Retinal Diseases

Start: Jun 2018Est. completion: Oct 20201,000,000 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.